Access said its hiring of Josh DeTillio as CEO and a new role for Founder Chris Gallagher as chief strategy officer build on recent milestones—including achieving all-time-high clinical performance numbers and the strongest financials in the company’s history.
Successful medical outcomes rely heavily on medication adherence, according to a Berkshire Biomedical. That's why the Dallas startup is developing tech that can dispense secure medication with a dosage specific only to the intended user. The system is currently under review with the U.S. Food and Drug Administration for market clearance.
The Dallas-based startup's tech is set to prevent medication non-adherence, which accounts for avoidable healthcare spending in the range of $100 to $300 billion.
Ireland-based H&MV Engineering planted its North American headquarters in Dallas. The move is part of a push to create 1,000 new U.S. jobs and reach $3.5 billion in revenue over the next five years....
The Colossal Foundation and the IUCN Species Survival Commission launched a four-year, $4 million partnership to accelerate species conservation. The foundation is the nonprofit arm of Dallas-based de-extinction company Colossal Biosciences....
Ireland-based H&MV Engineering planted its North American headquarters in Dallas. The move is part of a push to create 1,000 new U.S. jobs and reach $3.5 billion in revenue over the next five years....
The Colossal Foundation and the IUCN Species Survival Commission launched a four-year, $4 million partnership to accelerate species conservation. The foundation is the nonprofit arm of Dallas-based de-extinction company Colossal Biosciences....